Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating safety and efficacy of RP-L201 in subjects with Leukocyte Adhesion Deficiency-I (Phase 1/2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocyte Adhesion Deficiency Type

Drugs mentioned

• RP-L201

Snippet

Sponsor: Rocket Pharmaceuticals Inc. | Conditions: Leukocyte Adhesion Defect - Type I | Phase 1, Phase 2 | Status: COMPLETED